Trellus Management Company, LLC Paratek Pharmaceuticals, Inc. Transaction History

Trellus Management Company, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 20, 2023	SELL	$1.37 - $2.54 $230,160 - $426,720	-168,000 Reduced 56.95%	127,000 $322,000
Q3 2021 Oct 26, 2021	BUY	$4.7 - $7.24 $49,820 - $76,744	10,600 Added 3.73%	295,000 $1.43 Million
Q2 2021 Jul 30, 2021	SELL	$6.81 - $10.93 $378,636 - $607,708	-55,600 Reduced 16.35%	284,400 $1.94 Million
Q4 2020 Feb 10, 2021	BUY	$4.58 - $7.14 $183,200 - $285,600	40,000 Added 13.33%	340,000 $2.13 Million
Q2 2020 Aug 12, 2020	BUY	$2.97 - $5.22 $214,731 - $377,406	72,300 Added 31.75%	300,000 $1.57 Million
Q1 2020 May 06, 2020	BUY	$2.67 - $4.97 $215,322 - $400,805	80,645 Added 54.84%	227,700 $717,000
Q4 2019 Feb 20, 2020	SELL	$2.93 - $4.5 $111,178 - $170,752	-37,945 Reduced 20.51%	147,055 $593,000
Q3 2019 Nov 01, 2019	BUY	$3.08 - $5.76 $61,600 - $115,200	20,000 Added 12.12%	185,000 $799,000
Q2 2019 Jul 31, 2019	BUY	$3.47 - $6.32 $225,550 - $410,800	65,000 Added 65.0%	165,000 $658,000
Q1 2019 Apr 23, 2019	BUY	$5.36 - $7.24 $154,368 - $208,512	28,800 Added 40.45%	100,000 $536,000
Q4 2018 Feb 04, 2019	SELL	$4.8 - $11.6 $138,240 - $334,080	-28,800 Reduced 28.8%	71,200 $365,000
Q2 2018 Jul 25, 2018	BUY	$10.2 - $13.9 $105,059 - $143,170	10,300 Added 11.48%	100,000 $1.02 Million
Q1 2018 May 02, 2018	BUY	$12.65 - $18.85 $628,705 - $936,845	49,700 Added 124.25%	89,700 $1.17 Million
Q4 2017 Feb 02, 2018	BUY	$17.45 - $25.6 $349,000 - $512,000	20,000 Added 100.0%	40,000 $716,000
Q3 2017 Oct 19, 2017	BUY	$18.9 - $28.2 $378,000 - $564,000	20,000	20,000 $502,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Trellus Management Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Trellus Management Company, LLC with notifications on news.